Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 39.37% | 38.50% | 30.95% | 20.76% | 30.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.37% | 38.50% | 30.95% | 20.76% | 30.16% |
| Cost of Revenue | 28.22% | 25.64% | 12.13% | 14.44% | 24.12% |
| Gross Profit | 46.33% | 46.69% | 43.95% | 24.76% | 34.24% |
| SG&A Expenses | 30.57% | 23.08% | 39.00% | 26.75% | 33.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.72% | 18.03% | 21.88% | 17.15% | 21.58% |
| Operating Income | 4.00% | 15.48% | -5.85% | -11.04% | -9.95% |
| Income Before Tax | -18.07% | 14.05% | 2.57% | 17.20% | 41.21% |
| Income Tax Expenses | -341.20% | 353.33% | -71.43% | -28.40% | 232.35% |
| Earnings from Continuing Operations | -15.75% | 13.95% | 2.66% | 17.24% | 40.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.75% | 13.95% | 2.66% | 17.24% | 40.65% |
| EBIT | 4.00% | 15.48% | -5.85% | -11.04% | -9.95% |
| EBITDA | 4.01% | 15.91% | -7.19% | -12.90% | -11.39% |
| EPS Basic | -11.34% | 15.17% | 3.96% | 18.68% | 43.17% |
| Normalized Basic EPS | 0.68% | 14.13% | -13.38% | -4.06% | -8.51% |
| EPS Diluted | -11.34% | 15.17% | 3.96% | 18.68% | 43.17% |
| Normalized Diluted EPS | 0.68% | 14.13% | -13.38% | -4.06% | -8.51% |
| Average Basic Shares Outstanding | 3.96% | 1.43% | 1.36% | 1.77% | 4.43% |
| Average Diluted Shares Outstanding | 3.96% | 1.43% | 1.36% | 1.77% | 4.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |